Free Trial

Totally (TLY) Competitors

Totally logo
GBX 7.84 +0.10 (+1.23%)
(As of 09:55 AM ET)

TLY vs. KNB, SPI, MGP, SBI, CREO, KOO, REDX, ETX, VLG, and DNL

Should you be buying Totally stock or one of its competitors? The main competitors of Totally include Kanabo Group (KNB), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Creo Medical Group (CREO), Kooth (KOO), Redx Pharma (REDX), e-therapeutics (ETX), Venture Life Group (VLG), and Diurnal Group (DNL). These companies are all part of the "medical" sector.

Totally vs.

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings.

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£106.68M0.14-£3.13M-£0.02-392.25
Kanabo Group£1.14M4.99-£8.18M-£0.01-90.00

In the previous week, Totally's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
Totally Neutral
Kanabo Group Neutral

51.3% of Totally shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 13.3% of Totally shares are owned by insiders. Comparatively, 37.0% of Kanabo Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Totally presently has a consensus target price of GBX 20, indicating a potential upside of 154.94%. Given Totally's stronger consensus rating and higher possible upside, equities research analysts plainly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
TotallyOutperform Votes
131
72.78%
Underperform Votes
49
27.22%
Kanabo GroupN/AN/A

Totally has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, meaning that its stock price is 204% more volatile than the S&P 500.

Kanabo Group has a net margin of 0.00% compared to Totally's net margin of -2.94%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.94% -8.85% -2.42%
Kanabo Group N/A -83.19%-20.89%

Summary

Totally beats Kanabo Group on 9 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLY vs. The Competition

MetricTotallyMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£15.42M£1.40B£5.14B£1.40B
Dividend Yield13.16%3.79%4.81%11.74%
P/E Ratio-392.25235.00135.301,558.04
Price / Sales0.1457.921,186.56311,012.94
Price / Cash9.0812.9440.4232.94
Price / Book0.462.304.872.85
Net Income-£3.13M£52.03M£118.61M£152.80M
7 Day Performance-0.39%0.11%15.32%18.96%
1 Month Performance-14.26%7.37%15.26%18.69%
1 Year Performance53.82%15.00%34.42%23.73%

Totally Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLY
Totally
N/AGBX 7.85
+1.2%
GBX 20
+154.9%
+51.9%£15.42M£106.68M-375.001,668Gap Down
KNB
Kanabo Group
N/AGBX 0.90
flat
N/A-17.1%£5.69M£1.14M-95.0020
SPI
Spire Healthcare Group
2.5581 of 5 stars
GBX 228
-0.2%
GBX 322
+41.2%
-0.7%£920.71M£1.44B3,278.57420
MGP
Medica Group
N/AGBX 211
flat
N/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AGBX 115
+4.5%
N/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
CREO
Creo Medical Group
N/AGBX 17.53
+3.9%
N/A-50.0%£63.40M£30.30M-285.83279Insider Trade
News Coverage
KOO
Kooth
2.4081 of 5 stars
GBX 168.60
-0.8%
GBX 585
+247.0%
N/A£61.51M£54.17M1,416.67478News Coverage
Positive News
REDX
Redx Pharma
N/AGBX 15
+31.6%
N/AN/A£58.35M£4.20M-150.00101Gap Up
High Trading Volume
ETX
e-therapeutics
N/AGBX 9
-6.7%
N/AN/A£52.59M£295,000.00-450.0035High Trading Volume
VLG
Venture Life Group
N/AGBX 37
flat
N/A+11.2%£47.01M£51.41M3,725.00165
DNL
Diurnal Group
N/AGBX 27.30
flat
N/AN/A£46.33M£4.68M-3.2133

Related Companies and Tools


This page (LON:TLY) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners